Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in Multiple Myeloma
Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.
Elizabeth Aronson Breaks Down Data From Behind Talquetamab Approval in Multiple Myeloma
Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MonumenTAL-1 study assessing talquetamab in multiple myeloma.
MPN-Associated Anemia: What Nurses Should Look Out For
Oncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Jennifer Cargile on Managing Cancer-Related Cognitive Impairment
Jennifer Cargile, MEd, CCC-SLP, shares some examples of how she helped patients continue their daily activities while they experienced symptoms of cancer-related cognitive impairment.
Charina Toste Discusses the Educational Obstacles Patients With MPNs Face
According to Charina Toste, DNP, APRN-C, AOCNP, MSN, BSN, RN, patients with newly diagnosed myeloproliferative neoplasms may be unaware of the questions they should be asking their providers.
Lindsey Lyle on Differentiating MPN Symptoms From Other Health Issues
Lindsey Lyle, PA-C, MS, discusses how oncology nurses can work with their patients to determine if symptoms are related to their myeloproliferative neoplasm or another health condition.
Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse Events
Meredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Yelena Shames on Pausing Immunotherapy for Laboratory Abnormalities
Yelena Shames, MSA, ACNP-BC, CNRN, discusses when immune checkpoint inhibitor treatment should be paused because of laboratory abnormalities.
Johanna Garibaldi On Strengthening Cancer Prevention Tactics With Mobile Screening Clinics
Johanna Garibaldi, BSN, RN, EMT-P, discusses how a mobile clinic improved cancer screening rates among local firefighters.
Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis Management Strategy in Head and Neck Cancers
Elizabeth R. Cullen, MSN, ARNP, provides an overview of avasopasem manganese and its potential role in reducing severe oral mucositis for patients undergoing radiotherapy.
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care
Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Seth Eisenberg Compares the Effectiveness of Plastic-Backed Pads Vs The Splashblocker in Reducing Toilet Aerosols
Seth Eisenberg, ASN, RN, OCN, BMTCN, discusses his research comparing plastic-backed pads and the Splashblocker.
Pattie Jakel Highlights the Challenges With Oral Therapies in Breast Cancer
Patricia Jakel, RN, MN, AOCN, underscores some of the challenges nurses face when promoting adherence to oral medications.
Kellie Zeichner Speaks to the Power of Standardized Monitoring Procedures for Patients With Rare Tumors
Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer
Brenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast Cancer
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology Nurse
Melanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.
AnnMarie Walton on Reducing Antineoplastic Drug Residue in Inpatient Units
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses her research on plastic-backed pads and discusses the importance of better methods to reduce exposure to antineoplastic drug residue.
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient Ambulation
Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Heather Niccum Haag on Improving Patient Education With Belzutifan
Heather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.
Elizabeth Loach on Integrating Frontline Staff in Nursing Task Forces
Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Nurse Investigators on Using Weighted Blankets to Alleviate Anxiety During Cancer Treatment Infusions
Oncology nurse investigators from Dana-Farber discuss the value of weighted blankets in reducing patient anxiety during infusions.
Jessica MacIntyre on Improving LLS Referrals For Patients With Hematologic Malignancies
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, discusses ways to standardize the process of referring patients to the Leukemia and Lymphoma Society.
Stephanie Jackson on Improving the Double Verification Process For High-Alert Medications
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, highlights how her unit leveraged an educational video to improve compliance with double verification for high-alert medications.
Eric Zack on Disseminated Intravascular Coagulation Prevention and Management
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
Donna Catamero Discusses Managing Teclistamab-Induced CRS for Patients With Multiple Myeloma
Donna Catamero, ANP-BC, OCN, CCRC, outlines best management strategies for treating patients receiving teclistamab who experience cytokine release syndrome.
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation
Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Meghan Berkenstock on Managing Ocular Toxicities With ADCs in Cervical and Ovarian Cancers
Meghan K. Berkenstock, MD, discusses the growing need for strong collaboration between ophthalmologists and gynecologic oncology care teams.
Mary Katherine Montes de Oca on Cryocompression Therapy For Peripheral Neuropathy in Gynecologic Cancers
Mary Katherine Montes de Oca, MD, discusses the potential benefit of cryocompression therapy in preventing peripheral neuropathy in patients with gynecologic cancers who are receiving chemotherapy.
Following Reconstruction, Patients With Early Breast Cancer May Safely Opt For a Shorter Course of Radiation Therapy
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
2 Clarke Drive Cranbury, NJ 08512